Tempo Scan Pacific Tbk - Asset Resilience Ratio
Tempo Scan Pacific Tbk (TSPC) has an Asset Resilience Ratio of 0.38% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check TSPC capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Tempo Scan Pacific Tbk's Asset Resilience Ratio has changed over time. See TSPC equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Tempo Scan Pacific Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tempo Scan Pacific Tbk (TSPC) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp48.88 Billion | 0.38% |
| Total Liquid Assets | Rp48.88 Billion | 0.38% |
Asset Resilience Insights
- Limited Liquidity: Tempo Scan Pacific Tbk maintains only 0.38% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tempo Scan Pacific Tbk Industry Peers by Asset Resilience Ratio
Compare Tempo Scan Pacific Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
Drug Manufacturers - Specialty & Generic | 0.76% |
|
Eris Lifesciences Limited
NSE:ERIS |
Drug Manufacturers - Specialty & Generic | 0.58% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Lotus Pharmaceutical Co Ltd
TW:1795 |
Drug Manufacturers - Specialty & Generic | 0.49% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Sun Pharma Advanced Research Company Limited
NSE:SPARC |
Drug Manufacturers - Specialty & Generic | 0.64% |
Annual Asset Resilience Ratio for Tempo Scan Pacific Tbk (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Tempo Scan Pacific Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.02% | Rp127.94 Billion ≈ $7.50 Million |
Rp12.49 Trillion ≈ $731.82 Million |
-0.53pp |
| 2023-12-31 | 1.55% | Rp175.33 Billion ≈ $10.27 Million |
Rp11.32 Trillion ≈ $663.06 Million |
+0.64pp |
| 2022-12-31 | 0.91% | Rp102.85 Billion ≈ $6.03 Million |
Rp11.33 Trillion ≈ $663.83 Million |
-0.03pp |
| 2021-12-31 | 0.94% | Rp90.40 Billion ≈ $5.30 Million |
Rp9.64 Trillion ≈ $565.12 Million |
+0.37pp |
| 2020-12-31 | 0.57% | Rp51.60 Billion ≈ $3.02 Million |
Rp9.10 Trillion ≈ $533.50 Million |
-0.46pp |
| 2019-12-31 | 1.02% | Rp85.60 Billion ≈ $5.02 Million |
Rp8.37 Trillion ≈ $490.61 Million |
+0.70pp |
| 2018-12-31 | 0.32% | Rp24.99 Billion ≈ $1.46 Million |
Rp7.87 Trillion ≈ $461.15 Million |
+0.18pp |
| 2017-12-31 | 0.14% | Rp10.16 Billion ≈ $595.18K |
Rp7.43 Trillion ≈ $435.66 Million |
-0.78pp |
| 2016-12-31 | 0.92% | Rp60.31 Billion ≈ $3.53 Million |
Rp6.59 Trillion ≈ $385.90 Million |
+0.19pp |
| 2015-12-31 | 0.73% | Rp45.61 Billion ≈ $2.67 Million |
Rp6.28 Trillion ≈ $368.26 Million |
+0.10pp |
| 2014-12-31 | 0.62% | Rp34.84 Billion ≈ $2.04 Million |
Rp5.59 Trillion ≈ $327.71 Million |
-0.76pp |
| 2013-12-31 | 1.38% | Rp74.80 Billion ≈ $4.38 Million |
Rp5.41 Trillion ≈ $316.88 Million |
-0.31pp |
| 2012-12-31 | 1.69% | Rp78.38 Billion ≈ $4.59 Million |
Rp4.63 Trillion ≈ $271.47 Million |
+0.12pp |
| 2011-12-31 | 1.58% | Rp66.95 Billion ≈ $3.92 Million |
Rp4.25 Trillion ≈ $249.06 Million |
+0.12pp |
| 2010-12-31 | 1.46% | Rp52.38 Billion ≈ $3.07 Million |
Rp3.59 Trillion ≈ $210.34 Million |
-0.36pp |
| 2009-12-31 | 1.82% | Rp59.27 Billion ≈ $3.47 Million |
Rp3.26 Trillion ≈ $191.20 Million |
-0.03pp |
| 2008-12-31 | 1.85% | Rp54.85 Billion ≈ $3.21 Million |
Rp2.97 Trillion ≈ $173.86 Million |
-1.52pp |
| 2007-12-31 | 3.37% | Rp93.47 Billion ≈ $5.48 Million |
Rp2.77 Trillion ≈ $162.49 Million |
-0.41pp |
| 2006-12-31 | 3.78% | Rp93.82 Billion ≈ $5.50 Million |
Rp2.48 Trillion ≈ $145.27 Million |
-0.31pp |
| 2005-12-31 | 4.09% | Rp95.96 Billion ≈ $5.62 Million |
Rp2.35 Trillion ≈ $137.45 Million |
-42.46pp |
| 2004-12-31 | 46.56% | Rp996.95 Billion ≈ $58.42 Million |
Rp2.14 Trillion ≈ $125.48 Million |
+4.68pp |
| 2003-12-31 | 41.87% | Rp813.72 Billion ≈ $47.68 Million |
Rp1.94 Trillion ≈ $113.87 Million |
-0.51pp |
| 2002-12-31 | 42.38% | Rp769.89 Billion ≈ $45.11 Million |
Rp1.82 Trillion ≈ $106.44 Million |
-0.35pp |
| 2001-12-31 | 42.73% | Rp710.98 Billion ≈ $41.66 Million |
Rp1.66 Trillion ≈ $97.50 Million |
+8.41pp |
| 2000-12-31 | 34.32% | Rp490.20 Billion ≈ $28.72 Million |
Rp1.43 Trillion ≈ $83.69 Million |
-- |
About Tempo Scan Pacific Tbk
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and… Read more